BT Lab
SKU:E3176Hu
Human Atrial natriuretic peptide receptor 3,NPR3 ELISA Kit
Human Atrial natriuretic peptide receptor 3,NPR3 ELISA Kit
Couldn't load pickup availability
Contact us for 48 wells and bulk quote The Human Atrial Natriuretic Peptide Receptor 3, NPR3 ELISA Kit is a highly advanced and reliable diagnostic tool designed for the accurate measurement of NPR3 levels in human samples. This ELISA kit utilizes a solid-phase sandwich enzyme-linked immunosorbent assay technique, ensuring precise and sensitive detection of NPR3.
The NPR3 ELISA Kit is specifically engineered to provide researchers and clinicians with a comprehensive understanding of the NPR3 receptor's role in various physiological and pathological processes. With its exceptional sensitivity and specificity, this kit enables the quantification of NPR3 levels in a wide range of human samples, including serum, plasma, and other biological fluids.
This ELISA kit features a user-friendly protocol, allowing for easy and efficient execution of experiments. The kit includes all the necessary components, including pre-coated microplate wells, standards, controls, and reagents, ensuring convenience and accuracy throughout the assay procedure.
The NPR3 ELISA Kit offers a wide dynamic range, enabling the detection of NPR3 levels in both low and high concentrations. The kit exhibits excellent precision and reproducibility, ensuring consistent and reliable results. Furthermore, the kit's high sensitivity allows for the detection of even the smallest changes in NPR3 levels, making it an invaluable tool for research and clinical applications.
The Human Atrial Natriuretic Peptide Receptor 3, NPR3 ELISA Kit is an indispensable resource for scientists and healthcare professionals seeking to investigate the role of NPR3 in cardiovascular diseases, hypertension, and other related conditions. Its exceptional performance and accuracy make it an essential addition to any laboratory or clinical setting, facilitating groundbreaking research and aiding in the development of novel therapeutic interventions.
Share
